↓ Skip to main content

Dove Medical Press

Article Metrics

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
28 Mendeley
Title
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
Published in
Neuropsychiatric Disease and Treatment, April 2021
DOI 10.2147/ndt.s301225
Authors

Ágota Barabássy, Barbara Sebe, Károly Acsai, István Laszlovszky, Balázs Szatmári, Willie R Earley, György Németh

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 11%
Other 3 11%
Student > Bachelor 3 11%
Unspecified 2 7%
Researcher 2 7%
Other 5 18%
Unknown 10 36%
Readers by discipline Count As %
Psychology 5 18%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Unspecified 2 7%
Neuroscience 2 7%
Medicine and Dentistry 2 7%
Other 3 11%
Unknown 11 39%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2021.
All research outputs
#13,395,397
of 20,754,071 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,519
of 2,840 outputs
Outputs of similar age
#190,393
of 330,444 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#5
of 7 outputs
Altmetric has tracked 20,754,071 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,840 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,444 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.